Загрузка...
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma
External beam radiation therapy (XRT) with concomitant temozolomide and 6 cycles of adjuvant temozolomide (5/28-day schedule) improves survival in patients with newly diagnosed glioblastoma compared with XRT alone. Studies suggest that dose-dense temozolomide schedules and addition of cytostatic age...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3098026/ https://ncbi.nlm.nih.gov/pubmed/20729242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noq100 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|